Andrea J. Corcoran's most recent trade in Atea Pharmaceuticals Inc was a trade of 60,000 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on March 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 11 Mar 2026 | 60,000 | 823,576 | - | 1.2 | 74,400 | Common Stock |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2026 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 54,866 | 779,680 | - | - | Common Stock | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 44,366 | 0 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.24 per share. | 31 Jan 2026 | 16,104 | 763,576 | - | 4.2 | 68,281 | Common Stock |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 10,500 | 0 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 44,367 | 44,366 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 44,367 | 722,909 | - | - | Common Stock | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.06 per share. | 31 Jan 2025 | 16,102 | 717,307 | - | 3.1 | 49,272 | Common Stock |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,500 | 10,500 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,500 | 733,409 | - | - | Common Stock | |
| Atea Pharma Inc | J. Andrea Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,367 | 686,051 | - | - | Common Stock | |
| Atea Pharma Inc | J. Corcoran Andrea | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,367 | 88,733 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea Corcoran J. | See Remarks | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 31 Jan 2024 | 15,843 | 670,208 | - | 3.8 | 60,915 | Common Stock |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 186,300 | 186,300 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 133,100 | 133,100 | - | - | Restricted Stock Units | |
| Atea Pharma Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 181,000 | 181,000 | - | - | Stock Option (Right to Buy) |